Aquarius Surgical Technologies Inc.
AQQRF
$0.0042
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -47.59% | -20.45% | 15.53% | -2.25% | -17.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -47.59% | -20.45% | 15.53% | -2.25% | -17.80% |
| Cost of Revenue | -33.28% | -15.53% | -33.33% | -42.18% | -51.25% |
| Gross Profit | -56.41% | -24.42% | 89.98% | 56.42% | 42.30% |
| SG&A Expenses | 1.96% | -18.02% | -6.35% | -20.08% | -24.25% |
| Depreciation & Amortization | 4.27% | 40.63% | 114.95% | 294.83% | 75.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.85% | -16.15% | -7.33% | -20.42% | -27.07% |
| Operating Income | -16.92% | 14.77% | 13.11% | 26.15% | 30.29% |
| Income Before Tax | -38.11% | -16.69% | -8.92% | -1.44% | 27.52% |
| Income Tax Expenses | 246.67% | 246.67% | 246.67% | -- | -- |
| Earnings from Continuing Operations | -38.80% | -17.36% | -9.61% | -2.65% | 27.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.80% | -17.36% | -9.61% | -2.65% | 27.30% |
| EBIT | -16.92% | 14.77% | 13.11% | 26.15% | 30.29% |
| EBITDA | -17.68% | 16.17% | 15.62% | 28.45% | 31.14% |
| EPS Basic | -39.53% | -12.44% | -0.95% | 9.38% | 37.00% |
| Normalized Basic EPS | -21.43% | 2.78% | 13.07% | 23.64% | 30.77% |
| EPS Diluted | -39.53% | -12.44% | -0.95% | 9.38% | 37.00% |
| Normalized Diluted EPS | -21.43% | 2.78% | 13.07% | 23.64% | 30.77% |
| Average Basic Shares Outstanding | 0.05% | 2.95% | 6.85% | 11.07% | 15.51% |
| Average Diluted Shares Outstanding | 0.05% | 2.95% | 6.85% | 11.07% | 15.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
